Skip to main content
Year archive

Biotest AG — 2023 filings

All 46 regulatory filings released by Biotest AG (BIO3) in 2023, sourced directly from the official regulator.

46 Filings
2023 Period
2023 filings (46)
Filing Released Lang
Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP)
Regulatory Filings
2023-12-12 English
Biotests Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
Regulatory Filings
2023-11-28 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report 9M 2023
2023-11-06 English
Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
Earnings Release 9M 2023
2023-11-02 English
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-02 English
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-02 German
Biotest AG: Increase of the EBIT guidance
Earnings Release FY 2023
2023-10-05 English
Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
Board/Management Information
2023-10-05 English
Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo in the UK
Regulatory Filings
2023-09-21 English
Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
Legal Proceedings Report
2023-09-12 English
Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
Legal Proceedings Report
2023-09-07 English
Biotest AG: Biotest treats first shingles patient with Varitect CP in VARIZOSTA study
Regulatory Filings
2023-09-05 English
Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jorg Schuttrumpf by 5 years
Board/Management Information
2023-09-04 English
Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023
Earnings Release H1 2023
2023-08-10 English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.06.2023
Interim / Quarterly Report H1 2023
2023-08-10 German
Half-yearly financial report 2023
Interim / Quarterly Report H2 2023
2023-08-10 English
Biotest AG: Biotest increases EBIT to Euro 19.8 million
Earnings Release H1 2023
2023-07-27 English
Biotest AG: Biotest presents gigantic artwork to visualize its sustainability initiatives
Regulatory Filings
2023-06-01 English
Biotest AG: Annual General Meeting of Biotest AG elects Raimon Grifols Roura to the Supervisory Board
Board/Management Information
2023-05-09 English
Q1 statement / Q1 financial report 2023
Interim / Quarterly Report Q1 2023
2023-05-09 English
Biotest AG: Biotests Hyperimmunoglobulin Cytotect CP receives five additional Marketing Authorisations in Europe
Regulatory Filings
2023-05-04 English
Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raised
Earnings Release FY 2023
2023-04-28 English
Biotest AG: Biotest AG opens 12th plasma collection centre in Hungary
Regulatory Filings
2023-04-25 English
Biotest AG: Biotest AG opens 10th plasma collection centre in Germany
Regulatory Filings
2023-04-20 English
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 09.05.2023 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2023-03-31 German
Biotest AG: Biotest achieves important milestone in phase III trial in acquired fibrinogen deficiency
Regulatory Filings
2023-03-30 English
Biotest AG: Biotest core business profitable at Euro 60.7 million
Earnings Release FY 2022
2023-03-23 English
Remunerations Report 2022
Remuneration Information
2023-03-23 English
Investor Presentation 2022
Investor Presentation FY 2022
2023-03-23 German
Investor Presentation 2022
Investor Presentation FY 2022
2023-03-23 English
Geschäftsbericht 2022
Annual Report FY 2022
2023-03-23 German
Annual financial report 2022
Annual Report FY 2022
2023-03-23 English
Biotest AG: Biotest donates human albumin for earthquake victims in Turkey
Regulatory Filings
2023-03-14 English
Management declaration 2023 (§315d HGB)
Governance Information
2023-03-10 English
Management declaration 2023 (§289f HGB)
Governance Information
2023-03-10 English
declaration of compliance 2022
Governance Information
2023-03-10 English
Report Publication Announcement 2023
Report Publication Announcement
2023-02-28 English
Report Publication Announcement 2023
Report Publication Announcement
2023-02-28 English
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-02-28 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement
2023-02-28 German
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-02-28 German
Biotest AG: Biotest Supervisory Board appoints new Management Board member
Board/Management Information
2023-02-10 English
Biotest AG: Biotest significantly exceeds EBIT guidance 2022
Earnings Release FY 2022
2023-02-09 English
Biotest AG: First patient treated with Cytotect CP Biotest in study after heart and lung transplantation
Regulatory Filings
2023-01-24 English
Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award
Environmental & Social Information
2023-01-19 English
Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial
Regulatory Filings
2023-01-10 English